Tirzepatide 5mg (Mounjaro)

💉 Tirzepatide (5 mg)

Tirzepatide is a once-weekly injectable medication that acts as a dual GIP and GLP-1 receptor agonist. It’s FDA-approved for:

• Type 2 diabetes (as Mounjaro)

• Chronic weight management (as Zepbound)

🔬 How It Works

Tirzepatide activates two gut hormone pathways:

• GLP-1 → Reduces appetite, slows gastric emptying, improves insulin secretion

• GIP → Enhances insulin sensitivity and may support better fat metabolism

Together, this leads to:

• Strong appetite suppression

• Improved blood sugar control

• Significant body fat reduction

📦 What 5 mg Means

5 mg is typically an early step-up dose, not the starting dose.

Standard medical titration usually looks like:

1. 2.5 mg (starter dose for 4 weeks)

2. 5 mg

3. 7.5 mg

4. 10 mg

5. 12.5 mg

6. 15 mg (max dose)

The goal of gradual increases is to reduce side effects.

📊 Expected Effects at 5 mg

At this dose many people experience:

• Noticeable appetite reduction

• Early weight loss

• Improved glucose control

• Reduced cravings

Higher doses generally produce greater weight loss, but also more side effects.

⚠️ Common Side Effects

• Nausea

• Diarrhea or constipation

• Fatigue

• Reduced appetite (sometimes very strong)

• Occasional heartburn

Most side effects improve after a few weeks.

Retatrutide 10mg (Bacteriostatic water not included)